BridgeMD
New treatment option for Non Muscle Invasive Bladder Cancer
Official title The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection
ClinicalTrials.gov ID: NCT06287541
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate the efficacy of using a urine biomarker test to guide the decision-making process regarding the necessity of reTURBT in NMIBC patients. The main question aims to answer whether patients with negative urine biomarker tests can safely avoid reTURBT without compromising recurrence-free survival.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with NMIBC who have undergone initial TURBT and are scheduled for reTURBT surgery as recommended by guidelines or chosen by their physicians;
- Patients who have tested negative for urine biomarkers after the initial TURBT and before the second TURBT;
- Age ≥ 18 years;
- Willingness to provide personal basic clinical information, as well as pathology and subsequent recurrence monitoring results;
- Willingness to sign informed consent.
You likely can't join if
- Patients with other non-urothelial malignant tumors (including prostate cancer and renal cell carcinoma);
- Patients previously diagnosed with muscle-invasive bladder cancer;
- Patients unable to undergo a second transurethral resection;
- Patients with incomplete sample pathology information;
- Any condition perceived by the researcher to potentially harm the people or prevent them from meeting or executing the study requirements;
- Patients unable to provide written informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Nanjing, Jiangsu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nanjing, Jiangsu, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.